Author of the publication

The meningococcal vaccine candidate neisserial surface protein A (NspA) binds to factor H and enhances meningococcal resistance to complement

, , , , , and . PLoS Pathogens, 6 (7): e1001027 (2010)PMID: 20686663.
DOI: 10.1371/journal.ppat.1001027

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

An Efficient Algorithm for Automating Classification of Chemical Reactions into Classes in Ugi's Reaction Scheme., and . Int. J. Chemoinformatics Chem. Eng., 2 (2): 1-14 (2012)Interactions between Neisseria meningitidis and the complement system, , , , and . Trends in Microbiology, 15 (5): 233--40 (May 2007)PMID: 17398100.Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans, , , , , , , , , and 13 other author(s). Proceedings of the National Academy of Sciences of the United States of America, 107 (8): 3770--3775 (February 2010)PMID: 20133713.Factor H-IgG Chimeric Proteins as a Therapeutic Approach against the Gram-Positive Bacterial Pathogen Streptococcus pyogenes., , , , , , and . Journal of immunology (Baltimore, Md. : 1950), 199 (11): 3828--3839 (December 2017)Neisserial lipooligosaccharide is a target for complement component C4b. Inner core phosphoethanolamine residues define C4b linkage specificity, , , , , , , , , and 4 other author(s). The Journal of Biological Chemistry, 278 (51): 50853--50862 (December 2003)PMID: 14525973.Binding of the complement inhibitor C4bp to serogroup B Neisseria meningitidis, , , , and . Journal of Immunology (Baltimore, Md.: 1950), 174 (10): 6299--6307 (May 2005)PMID: 15879129.Extension of Ugi's Scheme for Model-Driven Classification of Chemical Reactions., , and . Int. J. Chemoinformatics Chem. Eng., 4 (1): 26-51 (2015)The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance, , , , , , , , , and . Journal of Immunology (Baltimore, Md.: 1950), 177 (1): 501--510 (July 2006)PMID: 16785547.Defining targets for complement components C4b and C3b on the pathogenic neisseriae, , , , , , , and . Infection and Immunity, 76 (1): 339--350 (January 2008)PMID: 17984207.Factor H and Neisserial pathogenesis, and . Vaccine, (December 2008)PMID: 19388163.